Willow Acquires 2 Women’s Health Companies
Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps. The post Willow Acquires 2 Women’s Health Companies appeared first on MedCity News.
Medicine
Read More
Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva
Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb. The post Patients Deaths and Data Shortfall Spell the End for Cell…
ClarityCare Raises $16.5M to Speed Up Prior Authorizations
As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need. The post ClarityCare Raises $16.5M to Speed Up Prior Authorizations appeared first on MedCity News.
A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals
The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it. The…
How Experts Are Reacting to Trump’s Women’s Health Executive Order
Women’s health experts had mixed reactions to the Trump administration’s executive order on women’s health. The post How Experts Are Reacting to Trump’s Women’s Health Executive Order appeared first on MedCity News.
Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a…
Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure
Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring technology from San Francisco-based medical tech company BodyPort. The program expansion comes as health systems look for ways to identify deterioration in a…
In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care
CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care appeared first on MedCity News.
FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market
[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market appeared first on MedCity News.
CareValidate Launches Expanded HRT Offering
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on MedCity News.